MX9401295A - Fosfonatos sustituidos, los procedimientos para supreparacion y composiciones farmaceuticas que los contienen. - Google Patents

Fosfonatos sustituidos, los procedimientos para supreparacion y composiciones farmaceuticas que los contienen.

Info

Publication number
MX9401295A
MX9401295A MX9401295A MX9401295A MX9401295A MX 9401295 A MX9401295 A MX 9401295A MX 9401295 A MX9401295 A MX 9401295A MX 9401295 A MX9401295 A MX 9401295A MX 9401295 A MX9401295 A MX 9401295A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
supreparation
procedures
contain
substituted phosphonates
Prior art date
Application number
MX9401295A
Other languages
English (en)
Inventor
Simon Floret
Raymond Azoulay
Yves Guyon-Gellin
Pierre Maechler
Eric Niesor
Craig Bentzen
Lan Nguyen
Vinh Van Diep
Hieu Phan
Original Assignee
Symphar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphar Sa filed Critical Symphar Sa
Publication of MX9401295A publication Critical patent/MX9401295A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015—Esters of acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/44—Amides thereof
    • C07F9/4403—Amides thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4411—Amides of acyclic unsaturated acids

Abstract

Esta invención se refiere a fosfonatos novedosos sustituidos con un porción dialquilfenol, y a los procedimientos para su preparación. Se refiere adicionalmente a las composiciones farmacéuticas que contienen estos compuestos y a su uso terapéutico en enfermedades en las cuales se han implicado radicales oxígeno reactivo y, más específicamente, en el tratamiento de la ateroesclerosis.
MX9401295A 1993-02-19 1994-02-18 Fosfonatos sustituidos, los procedimientos para supreparacion y composiciones farmaceuticas que los contienen. MX9401295A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH52193 1993-02-19

Publications (1)

Publication Number Publication Date
MX9401295A true MX9401295A (es) 1994-08-31

Family

ID=4188911

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9401295A MX9401295A (es) 1993-02-19 1994-02-18 Fosfonatos sustituidos, los procedimientos para supreparacion y composiciones farmaceuticas que los contienen.

Country Status (8)

Country Link
EP (1) EP0638084A1 (es)
JP (1) JPH07506121A (es)
CN (1) CN1106611A (es)
AU (1) AU6205294A (es)
CA (1) CA2118409A1 (es)
MX (1) MX9401295A (es)
WO (1) WO1994019358A1 (es)
ZA (1) ZA941088B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433244A1 (de) * 1994-09-19 1996-03-28 Hoechst Ag Aminomethylphosphon- und Aminomethylphosphinsäure-Derivate und deren Verwendung zur Behandlung von degenerativen Gelenkserkrankungen
DE19502209A1 (de) * 1995-01-25 1996-08-01 Hoechst Ag Phosphonoessigsäure-Derivate und deren Verwendung zur Behandlung von degenerativen Gelenkserkrankungen
JP3588734B2 (ja) * 1996-07-26 2004-11-17 コニカミノルタホールディングス株式会社 電子写真感光体
AU2003272513A1 (en) * 2002-09-19 2004-04-08 Ilex Oncology Research, Sarl Substituted ketophosphonate inhibitors of tumor cell proliferation
EP1551418A4 (en) * 2002-09-19 2006-05-03 Ilex Oncology Res Sarl SUBSTITUTED KETOPHOSPHONATE COMPOUNDS WITH BONE ANABOLIC EFFECT
FR2876104B1 (fr) * 2004-10-04 2007-02-23 Centre Nat Rech Scient Composes fluorophosphonocinnamiques, systhese et aplications
GB0613518D0 (en) * 2006-07-06 2006-08-16 Phytopharm Plc Chemical compounds
JP5559186B2 (ja) * 2008-11-13 2014-07-23 ビーエーエスエフ ソシエタス・ヨーロピア ホスホノ基を含有するベンジリデン化合物
EP2270021A1 (en) * 2009-06-18 2011-01-05 Centre National de la Recherche Scientifique Phosphonates synthons for the synthesis of phosphonates derivatives showing better bioavailability
CN109154016B (zh) * 2017-12-29 2021-11-16 邦泰生物工程(深圳)有限公司 一种化学-酶法制备熊去氧胆酸的方法
CN108794559A (zh) * 2018-07-31 2018-11-13 重庆波克底科技开发有限责任公司 一种以猪去氧胆酸为原料合成石胆酸的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2024030A1 (de) * 1970-05-16 1971-12-02 Deutsche Advance Produktion GmbH, 6141 Lautern 2,6-Dialkylphenole
JPS5921889B2 (ja) * 1975-06-02 1984-05-23 帝人株式会社 ポリエステルの製造方法
JPS5782828A (en) * 1980-11-11 1982-05-24 Canon Inc Heat developing photosensitive material
DE3362618D1 (en) * 1982-10-07 1986-04-24 Ciba Geigy Ag Phenols and their preparation
CH675422A5 (es) * 1988-03-31 1990-09-28 Symphar Sa
JPH0377894A (ja) * 1989-08-18 1991-04-03 Toray Ind Inc メチレンジホスホン酸化合物
US5300687A (en) * 1991-07-18 1994-04-05 Ortho Pharmaceutical Corporation Trifluoromethylbenzylphosphonates useful in treating osteoporosis

Also Published As

Publication number Publication date
JPH07506121A (ja) 1995-07-06
AU6205294A (en) 1994-09-14
EP0638084A1 (en) 1995-02-15
ZA941088B (en) 1995-09-27
CN1106611A (zh) 1995-08-09
CA2118409A1 (en) 1994-09-01
WO1994019358A1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
ES2183937T3 (es) Inhibidores de la adhesion celular.
GT199700015A (es) Inhibidores de metaloproteinasa, composiciones farmaceuticas que las contienen y su uso farmaceutico y metodosyeficazproducto intermedio para su preparacion.
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
CU23393A3 (es) Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen
ES2181614T3 (es) Sulfonilfenilheterociclos sustituidos como inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa.
PA8462401A1 (es) Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos
ES2165441T3 (es) Inhibidores de calpaina y/o catepsina b oxazolidin sustituidos.
HN2002000154A (es) Azaindoles
UY24256A1 (es) Anticuerpos monoclonales de mono especificos para anticuerpos humanos b 7.1 y/o b7.2, formas primatizadas de los mis- mos, composiciones farmaceuticas que los contienen y uso de los mismos como inmunosupresores
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
ES2196377T3 (es) Derivados de naftiridina.
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
GT199900146A (es) Derivados de 4,4-biarilpiperidina.
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
GT199700089A (es) Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido.
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
ES2115237T3 (es) Fenil heterociclos como inhibidores de la ciclooxigenasa-2.
AR012294A1 (es) Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento.
MX9401295A (es) Fosfonatos sustituidos, los procedimientos para supreparacion y composiciones farmaceuticas que los contienen.
ITMI931649A1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
ES2066239T3 (es) Complejos fosfolipidicos de bilobalido, sus aplicaciones y formulados que los contienen.
ES2076595T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
ES2150461T3 (es) Derivados de amidinofenilalanina, proceso para su preparacion, su empleo y agentes que los contienen como anticoagulantes.